Hot Pursuit     13-Nov-23
Glaxosmithkline Pharmaceuticals Ltd spurts 0.29%, up for fifth straight session
Glaxosmithkline Pharmaceuticals Ltd is quoting at Rs 1486.15, up 0.29% on the day as on 12:44 IST on the NSE. The stock is up 11.1% in last one year as compared to a 6.07% jump in NIFTY and a 18.85% jump in the Nifty Pharma.

Glaxosmithkline Pharmaceuticals Ltd is up for a fifth straight session today. The stock is quoting at Rs 1486.15, up 0.29% on the day as on 12:44 IST on the NSE. The benchmark NIFTY is down around 0.43% on the day, quoting at 19442.55. The Sensex is at 64936.24, down 0.5%. Glaxosmithkline Pharmaceuticals Ltd has slipped around 3.34% in last one month.

Meanwhile, Nifty Pharma index of which Glaxosmithkline Pharmaceuticals Ltd is a constituent, has slipped around 2.04% in last one month and is currently quoting at 15562.65, down 0.57% on the day. The volume in the stock stood at 40695 shares today, compared to the daily average of 1.02 lakh shares in last one month.

The PE of the stock is 39.86 based on TTM earnings ending September 23.

Previous News
  Glaxosmithkline Pharmaceuticals fixes record date for final dividend
 ( Market Beat - Reports 30-May-23   12:47 )
  Glaxosmithkline Pharmaceuticals consolidated net profit rises 9.45% in the December 2022 quarter
 ( Results - Announcements 07-Feb-23   17:17 )
  Glaxosmithkline Pharmaceuticals Ltd spurts 0.29%, up for fifth straight session
 ( Hot Pursuit - 13-Nov-23   13:00 )
  Glaxosmithkline Pharmaceuticals Ltd spurts 2.77%, rises for third straight session
 ( Hot Pursuit - 10-Nov-23   13:06 )
  Glaxosmithkline Pharmaceuticals consolidated net profit declines 5.95% in the March 2020 quarter
 ( Results - Announcements 18-May-20   19:15 )
  GlaxoSmithKline Pharmaceuticals
 ( Results - Analysis 19-May-20   11:03 )
  Board of GlaxoSmithKline Pharmaceuticals recommends Special Dividend
 ( Corporate News - 19-May-20   10:21 )
  Board of GlaxoSmithKline Pharmaceuticals recommends Final Dividend
 ( Corporate News - 19-May-20   10:21 )
  Glaxosmithkline Pharmaceuticals standalone net profit declines 22.67% in the September 2018 quarter
 ( Results - Announcements 22-Oct-18   15:33 )
  Glaxosmithkline Pharmaceuticals Ltd leads losers in 'A' group
 ( Hot Pursuit - 04-Feb-20   15:00 )
  GlaxoSmithKline Pharmaceuticals schedules board meeting
 ( Corporate News - 10-Apr-19   10:06 )
Other Stories
  Dhanlaxmi Bank gains as gross advances rises 6% YoY in Q1 FY25
  05-Jul-24   15:27
  HDFC Bank Ltd leads losers in 'A' group
  05-Jul-24   15:00
  Shilpa Medicare sizzles after Unicycive gets positive results in clinical trials of OLC
  05-Jul-24   14:52
  Manugraph India Ltd leads losers in 'B' group
  05-Jul-24   14:45
  NSE SME Nephro Care India rallies on listing day
  05-Jul-24   14:45
  ESAF SFB total deposits jumps 33% YoY in Q1
  05-Jul-24   14:43
  Utkarsh SFB deposits climb 30% YoY in Q1 FY25
  05-Jul-24   14:35
  Volumes soar at Medplus Health Services Ltd counter
  05-Jul-24   14:30
  Financials stocks slide
  05-Jul-24   14:00
  Banking stocks edge lower
  05-Jul-24   14:00
Back Top